ARVINAS INC. - COMMON STOCK
25.66
12-November-24 14:15:19
15 minutes delayed
Stocks
-2.39
-8.51%
Today's range
24.92 - 27.76
ISIN
N/A
Source
NASDAQ
-
Arvinas Announces Chief Financial Officer Transition
20 Feb 2024 15:05:04 By Nasdaq GlobeNewswire
-
20 Feb 2024 06:00:44 By Nasdaq GlobeNewswire
-
06 Feb 2024 05:45:00 By Nasdaq GlobeNewswire
-
Arvinas to Present at 6th Annual Guggenheim Biotechnology Conference
01 Feb 2024 15:30:20 By Nasdaq GlobeNewswire
-
Arvinas Appoints Jared Freedberg as General Counsel
16 Jan 2024 16:01:06 By Nasdaq GlobeNewswire
-
05 Dec 2023 12:33:42 By Nasdaq GlobeNewswire
-
28 Nov 2023 16:05:13 By Nasdaq GlobeNewswire
-
Arvinas Announces Oversubscribed $350 Million Private Placement
27 Nov 2023 06:00:10 By Nasdaq GlobeNewswire
-
Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update
07 Nov 2023 06:00:34 By Nasdaq GlobeNewswire
-
Arvinas to Participate in Upcoming Investor Conferences
02 Nov 2023 06:00:59 By Nasdaq GlobeNewswire
-
22 Oct 2023 06:00:58 By Nasdaq GlobeNewswire
-
Arvinas Gives Back to Local Greater New Haven Community in Second Annual Impact Day
18 Oct 2023 06:00:27 By Nasdaq GlobeNewswire
-
Arvinas Announces Upcoming Bavdegalutamide Poster Presentation at ESMO Congress 2023
15 Oct 2023 17:07:41 By Nasdaq GlobeNewswire
-
15 Oct 2023 17:05:45 By Nasdaq GlobeNewswire
-
Arvinas to Participate in Upcoming Investor Conferences
01 Sep 2023 06:00:10 By Nasdaq GlobeNewswire
-
Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update
08 Aug 2023 06:00:18 By Nasdaq GlobeNewswire
-
Arvinas Announces Changes to its Board of Directors
15 Jun 2023 15:30:26 By Nasdaq GlobeNewswire